✦ LIBER ✦
Potential factors correlating to the PMDA’s decision to waive Japanese Phase 2 and 3 studies for oncology drugs New Drug Application in Japan
✍ Scribed by Keitaro Nakajima, Koji Chiba, Hisao Tsubamoto, Jaimie Walsh, Laurie Strawn, Toshio Suwa
- Book ID
- 120966751
- Publisher
- Springer US
- Year
- 2012
- Tongue
- English
- Weight
- 157 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.